April 1st 2025
Microbiome engineering offers strategies to modulate the skin microbiome, including non-targeted approaches like probiotics and targeted approaches like phage therapy.
Catch up on dermatology news, highlights, and insights from the past 24 hours.
March 31st 2025
This month and all year round, we recognize the strides and contributions of female leaders in dermatology.
Exclusive Q1 Report: A comprehensive look at the latest FDA approvals and pipeline developments in dermatology from the first quarter of 2025.
March 30th 2025
Explore the top headlines of the week including insights on clinical trials, CBD products, and more.
Potential Treatments for TSW Identified in NIH Study
A pilot study revealed that mitochondrial complex I-blocking drugs, like metformin and berberine, improved TSW symptoms in most participants.
Bridging the Gender Gap: Women Leading the Way
Join Dermatology Times in celebrating the women who make this field shine through their patient interactions, clinical insights, and research.
Daily Derm Times: March 17, 2025
Climate Change, Pollution’s Growing Impact on Dermatology
Experts stressed the importance of dermatologists engaging in climate advocacy and adopting sustainable practices, as their actions may inspire others to follow suit.
Top 5 Articles of the Week: March 9-14
Explore the top headlines of the week including insights on L'Oréal’s voluntary recall of benzoyl peroxide products, the impact of GLP-1 medications on skin health, and more 2025 conferences.
Dermatology Times' Sunday Crossword: March 16, 2025
Test your knowledge of key words and terms associated with dermatology news from the previous week.
The Weekly Roundup: March 10-14
In case you missed it, this week we had news about the FDA voluntary benzoyl peroxide recalls, the National Eczema Association's strategic efforts, recaps of this week’s AAD Annual Meeting, and more.
The Rx Recap: March 9-15
This week, we feature top articles from our sister publications on FDA updates, Medicaid pricing, and more.
Daily Derm Times: March 14, 2025
Amlitelimab Demonstrates Durable Response in Atopic Dermatitis
Karl Yen of Sanofi discussed the role of amlitelimab in AD following sustained results and a promising safety profile presented in data at AAD.
Key Insights from Novartis at AAD and AAAAI: Flexibility and Personalization in Dermatology Treatment
Novartis highlighted key findings at AAD and AAAAI, showcasing Cosentyx's flexible dosing for hidradenitis suppurativa and remibrutinib’s efficacy for chronic spontaneous urticaria.
Blending Clinical Practice and Social Media with Chris Tomassian, MD
By staying authentic and leveraging real patient experiences, Tomassian ensures his content remains valuable and trustworthy.
Daily Derm Times: March 13, 2025
Celebrating Second Annual National Dermatologist Day with Launch of EltaMD’s ‘Derm Difference’ Campaign
EltaMD’s Derm Difference campaign honors dermatologists’ expertise in skin health, cancer prevention, and confidence-boosting care.
Daily Derm Times: March 12, 2025
The Rx Recap: March 2-8
This week, we feature top articles from our sister publications on updates in surgical management, diabetes control, and more.
Journal Digest: March 12
This review of the latest dermatologic studies includes insights into erectile dysfunction in dermatology and venereology, diet and psoriasis information on TikTok, and more.
Dermatology Times' Weekly Crossword: AAD Annual Meeting Insights Edition
Test your knowledge of key words and terms associated with dermatology meeting news from the previous week.
Michael Gold, MD: Advances in Acne Treatment and Energy-Based Devices
Gold highlighted the growing role of energy-based devices in acne treatment during his AAD session.
Top 5 Articles of the Week: March 2-7
Explore the top headlines of the week including insights on the environmental impact of conferences, new clinical data, and the shift towards more natural-looking results.
Peter Lio, MD: Minimizing Discomfort in Dermatologic Procedures
Lio shared insights on minimizing pain in dermatologic procedures, highlighting practical techniques from his AAD 2025 presentations.
Advances in Treatment Resistant Port-Wine Birthmarks: Emerging Therapies and Future Directions
Expect exciting news in the treatment of port-wine birthmarks, Kristen Marie Kelly, MD, told AAD Annual Meeting attendees.
The Weekly Roundup: March 3-7
In case you missed it, this week we had news about the achievements of female dermatologists for Women’s History Month, Takeda’s initiative to improve clinical disparities in psoriasis research, previews of this week’s AAD Annual Meeting, and more.
Exploring the IBD-Dermatology Connection
Alexandra P. Charrow, MD, FAAD, shares insights on the link between dermatology and irritable bowel disease at the AAD Annual Meeting.
Previewing the 2025 AAD Annual Meeting: What to Expect and Tips from the Experts
Read more on how to navigate all the opportunities at this year’s AAD meeting, which starts today in Orlando, Florida.
Daily Derm Times: March 5, 2025
Q&A: Jonathan Bernstein, MD, FAAAAI, Discusses Advances in Chronic Spontaneous Urticaria Treatments and AAAAI Data
At AAAAI/WAO 2025, Bernstein explored new findings on rilzabrutinib and dupilumab in CSU, highlighting treatment gaps and future therapies.
Polyherbal Lip Hydrant Healed Chapped and Rough Lips, Compared to Petroleum Gel
The novel formulation improved the appearance of dry and chapped lips after 28 days of use.
Celebrating Women’s History Month by Honoring Women in Dermatology: A Sit-Down Interview With WDS Legacy Awardee Dr Adelaide Hebert
Dematology Times' Editor in Chief interviews Adelaide Hebert, MD, who will be honored at the AAD 2025 Legacy Celebration for her impact on pediatric dermatology.
Daily Derm Times: March 4, 2025
Challenges and Future Directions in Microbiome Engineering
High-Intensity Ultrasound Device Is Suitable for Facial Acne Scars in Asian Patients
Optimizing Vitiligo Care: Key Expert Takeaways
Dermatology Conferences and Meetings Calendar: April 2025